Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Recruiting · NCT06062745 · Registry updated 2025-11-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2025-11-05 | NCT06062745 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Blue Earth Diagnostics | 26 |
| Brigham and Women's Hospital | 378 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Womens Hospital | Boston | United States | 2 |
| Dana Farber Cancer Institute | Boston | United States | 133 |